• Login
    ARAN - Access to Research at NUI Galway
    View Item 
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ARANCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypesThis CollectionBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Help

    How to submit and FAQs

    The impact of dialysis on the survival of patients with immunoglobulin light chain (al) amyloidosis undergoing autologous stem cell transplantation

    Thumbnail
    View/Open
    Full Text
    Date
    2015-11-30
    Author
    Leung, Nelson
    Kumar, Shaji K.
    Glavey, Siobhan V.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kapoor, Prashant
    Zeldenrust, Steven R.
    Russell, Stephen J.
    Lust, John A.
    Hogan, William J.
    Rajkumar, S. Vincent
    Gastineau, Dennis A.
    Kourelis, Taxiarchis V.
    Lin, Yi
    Gonsalves, Wilson I.
    Go, Ronald S.
    Gertz, Morie A.
    Metadata
    Show full item record
    Usage
    This item's downloads: 0 (view details)
    Cited 11 times in Scopus (view citations)
    
    Recommended Citation
    Leung, Nelson; Kumar, Shaji K. Glavey, Siobhan V.; Dispenzieri, Angela; Lacy, Martha Q.; Buadi, Francis K.; Hayman, Suzanne R.; Dingli, David; Kapoor, Prashant; Zeldenrust, Steven R.; Russell, Stephen J.; Lust, John A.; Hogan, William J.; Rajkumar, S. Vincent; Gastineau, Dennis A.; Kourelis, Taxiarchis V.; Lin, Yi; Gonsalves, Wilson I.; Go, Ronald S.; Gertz, Morie A. (2015). The impact of dialysis on the survival of patients with immunoglobulin light chain (al) amyloidosis undergoing autologous stem cell transplantation. Nephrology Dialysis Transplantation 31 (8), 1284-1289
    Published Version
    https://academic.oup.com/ndt/article-pdf/31/8/1284/6838672/gfv328.pdf
    Abstract
    Acute renal failure requiring dialysis is associated with high mortality during autologous stem cell transplantation (ASCT). This study examined the association between acute renal failure and mortality in immunoglobulin light chain (AL) amyloidosis during ASCT. Between 1996 and 2010, 408 ASCT patients were evaluated. Data were collected from electronic medical records. Dialysis was performed on 72 (17.6%) patients. Eight patients started dialysis > 30 days prior to ASCT (Group II), 36 started +/- 30 days after ASCT (Group III) and 28 initiated dialysis > 1 month after ASCT (Group IV). Patients who never dialyzed were assigned to Group I. There were no significant age or sex differences. Median overall survival (OS) had not been reached in Groups I and II but was 7.0 months in Group III and 48.5 months in Group IV (P < 0.001). Treatment-related mortality (TRM) was observed in 44.4% of the patients in Group III, 6-fold higher than the next highest group (P < 0.001). The most common causes of TRM were cardiac and sepsis. In the multivariate analysis, only hypoalbuminemia (< 2.5 g/dL, P < 0.001) and estimated glomerular filtration rate (eGFR) < 40 mL/min/1.73 m(2) (P < 0.001) were independently associated with starting dialysis within 30 days of ASCT. The study found significant differences in the OS depending on when the acute renal failure occurred. Patients who required dialysis within 30 days of ASCT had the highest rate of TRM. Screening with serum albumin and eGFR may reduce the risk.
    URI
    http://hdl.handle.net/10379/12430
    Collections
    • Externally hosted open access publications with NUI Galway authors (2)
    • Copyright @ NUI Galway
    • Library
    • NUI Galway